Counting the costs of overweight and obesity: modeling clinical and cost outcomes

References

• Puska P, Nishida C, Porter D. Obesity and overweight. World Health Organization, 2003. Also >available from www.who.int/hpr/NPH/docs/gs_obesity.pdf [last accessed 2 June 2005]
   Google Scholar
• Center for Disease Control. Defining overweight and obesity http://www.cdc.gov/nccdphp/dnpa/obesity/defining.htm 2005
   Google Scholar
• Wild S, Roglic G, Green A, et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27:1047–53
   PubMed Web of Science ®Google Scholar
• Flegal KM, Carroll MD, Ogden CL, et al. Prevalence and trends in obesity among US adults, 1999–2000. J Am Med Assoc 2002;288:1723–7
   PubMed Web of Science ®Google Scholar
• Flegal KM, Carroll MD, Kuczmarski RJ, et al. Overweight and obesity in the United States: prevalence and trends, 1960–1994. Int J Obes Relat Metab Disord 1998;22:39–47
   PubMed Web of Science ®Google Scholar
• Hedley AA, Ogden CL, Johnson CL, et al. Prevalence of over-weight and obesity among US children, adolescents, and adults, 1999–2002. J Am Med Assoc 2004;291:2847–50
   PubMed Web of Science ®Google Scholar
• Raebel MA, Malone DC, Conner DA, et al. Health services use and health care costs of obese and nonobese individuals. Arch Intern Med 2004;164:2135–40
   PubMed Web of Science ®Google Scholar
• Finkelstein EA, Fiebelkorn IC, Wang G. State-level estimates of annual medical expenditures attributable to obesity. Obes Res 2004;12:18–24
   Google Scholar
• Bertakis KD, Azari R. Obesity and the use of health care services. Obes Res 2005;13:372–9
   PubMedGoogle Scholar
• Naimark D, Krahn MD, Naglie G, et al. Primer on medical decision analysis: part 5 – working with Markov processes. Med Decis Mak 1997;17:152–9
   PubMed Web of Science ®Google Scholar
• Briggs AH. Handling uncertainty in cost-effectiveness models. Pharmacoeconomics 2000;17:479–500
   PubMed Web of Science ®Google Scholar
• Sonnenberg FA, Beck JR. Markov models in medical decision making: a practical guide. Med Decis Mak 1993;13:322–38
   PubMed Web of Science ®Google Scholar
• World Health Organization. Obesity: preventing and managing the global epidemic. WHO: Geneva; 1997
   Google Scholar
• Fontaine KR, Redden DT, Wang C, et al. Years of life lost due to obesity. J Am Med Assoc 2003;289:187–93 [Mortality data available at www.soph.uab.edu/statgenetics/research/tables/yll.htm]
   Google Scholar
• Heo M, Faith MS, Mott JW, et al. Hierarchical linear models for the development of growth curves: an example with body mass index in overweight/obese adults. Stat Med 2003;22:1911–42
   PubMed Web of Science ®Google Scholar
• Peeters A, Barendregt JJ, Willekens F, et al. Obesity in adulthood and its consequences for life expectancy: a life-table analysis. Ann Intern Med 2003;138:24–32
   PubMed Web of Science ®Google Scholar
• Daviglus ML, Liu K, Yan LL, et al. Relation of body mass index in young adulthood and middle age to Medicare expenditures in older age. J Am Med Assoc 2004;292:2743–9
   PubMed Web of Science ®Google Scholar
• Thompson D, Edelsberg J, Colditz GA, et al. Lifetime health and economic consequences of obesity. Arch Intern Med 1999;159:2177–83
   PubMed Web of Science ®Google Scholar
• Allison DB, Zannolli R, Narayan KM. The direct health care costs of obesity in the United States. Am J Public Health 1999;89:1194–9
   PubMed Web of Science ®Google Scholar
• Hakim Z, Wolf A, Garrison LP. Estimating the effect of changes in body mass index on health state preferences. Pharmacoeconomics 2002;20:393–404
   Google Scholar
• Hauptman J, Lucas C, Boldrin MN, et al. Orlistat in the long-term treatment of obesity in primary care settings. Arch Fam Med 2000;9:160–7
   PubMedGoogle Scholar
• Burton WN, Chen CY, Schultz AB, et al. The economic costs associated with body mass index in a workplace. J Occup Environ Med 1998;40:786–92
   PubMed Web of Science ®Google Scholar
• US department of labor http://data.bls.gov/cgi-bin/cpicalc.pl 2005
   Google Scholar
• Tarn T, Smith M. Pharmacoeconomic guidelines around the world. ISPOR connections 2004. Also available from www. ispor.org [last accessed 2 May 2005]
   Google Scholar
• Detsky AS, Redelmeier DA. Measuring health outcomes – putting gains into perspective. New Engl J Med 1998;339:402–4
   PubMed Web of Science ®Google Scholar
• Wright JC, Weinstein MC. Gains in life expectancy from medical interventions – standardizing data on outcomes. New Engl J Med 1998;339:380–6
   PubMed Web of Science ®Google Scholar
• Naimark D, Naglie G, Detsky AS. The meaning of life expectancy: what is a clinically significant gain? J Gen Intern Med 1994;9:702–7
   Google Scholar
• Durazo-Arvizu R, Cooper RS, et al. Relative weight and mortality in U.S. blacks and whites: findings from representative national population samples. Ann Epidemiol 1997;7:383–95
   Google Scholar
• McGee DL. Body mass index and mortality: a meta-analysis based on person-level data from twenty-six observational studies. Ann Epidemiol 2005;15:87–97
   PubMed Web of Science ®Google Scholar
• Flegal KM, Graubard BI, Williamson DF, et al. Excess deaths associated with underweight, overweight, and obesity. J Am Med Assoc 2005;293:1861–7
   PubMed Web of Science ®Google Scholar
• Heiat A, Vaccarino V, Krumholz HM. An evidence-based assessment of federal guidelines for overweight and obesity as they apply to elderly persons. Arch Intern Med 2001;161:1194–203
   Google Scholar
• Strawbridge WJ, Wallhagen MI, Shema SJ. New NHLBI clinical guidelines for obesity and overweight: will they promote health? Am J Public Health 2000;90:340–3
   Google Scholar
• Fontaine KR, Cheskin LJ, Barofsky I. Health-related quality of life in obese persons seeking treatment. J Fam Pract 1996;43:265–70
   Google Scholar
• Fontaine KR, Bartlett SJ, Barofsky I. Health-related quality of life among obese persons seeking and not currently seeking treatment. Int J Eat Disord 2000;27:101–5
   Google Scholar
• Lean ME, Han TS, Seidell JC. Impairment of health and quality of life using new US federal guidelines for the identification of obesity. Arch Intern Med 1999;159:837–43
   Google Scholar
• Dorn JM, Schisterman EF, Winkelstein Jr W, et al. Body mass index and mortality in a general population sample of men and women [The Buffalo Health Study]. Am J Epidemiol 1997;146:919–31
   PubMed Web of Science ®Google Scholar
• Seidell JC, Hans TS, Feskens EJ, et al. Narrow hips and broad waist circumferences independently contribute to increased risk of non-insulin-dependent diabetes mellitus. J Intern Med 1997;242:401–6
   PubMed Web of Science ®Google Scholar
• DiPietro L, Katz LD, Nadel ER. Excess abdominal adiposity remains correlated with altered lipid concentrations in healthy older women. Int J Obes Relat Metab Disord 1999;23:432–6
   Google Scholar
• Beegom R, Niaz MA, Singh RB. Diet, central obesity and prevalence of hypertension in the urban population of south India. Int J Cardiol 1995;51:183–91
   Google Scholar
• Pouliot MC, Despres JP, Lemieux S, et al. Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol 100473:460–8
   Google Scholar
• Ledoux M, Lambert J, Reeder BA. A comparative analysis of weight to height and waist to hip circumference indices as indicators of the presence of cardiovascular disease risk factors [Canadian heart health surveys research group]. Can Med Assoc J 1997;157(Suppl 1):s32–s38
   Google Scholar
• Dobbelsteyn CJ, Joffres MR, Maclean DR, et al. A comparative evaluation of waist circumference, waist-to-hip and body mass index as indicators of cardiovascular risk factors [The Canadian heart health surveys]. Int J Obes Relat Metab Disord 2001;25:652–61
   PubMed Web of Science ®Google Scholar
• Seidell JC, Cigolini M, Charzewska J, et al. Fat distribution in European women: a comparison of anthropometric measurements in relation to cardiovascular risk factors. Int J Epidemiol 1990;19:303–8
   PubMed Web of Science ®Google Scholar